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Multipotency and self-renewal are considered as most important features of stem cells to persist throughout life in tissues. In this
context,theroleofHMGAproteinstoinﬂuenceproliferationofadipose-derivedmesenchymalstemcell(ASCs)whilemaintaining
their multipotent and self-renewal capacities has not yet been investigated. Therefore, extracellular HMGA1 and HMGA2
application alone (10–200ng/mL) and in combination with each other (100, 200ng/mL each) was investigated with regard to
proliferativeeﬀectsoncanineASCs(cASCs)after48hoursofcultivation.Furthermore,mRNAexpressionofmultipotencymarker
genes in unstimulated and HMGA2-stimulated cASCs (50, 100ng/mL) was analyzed by RT-qPCR. HMGA1 signiﬁcantly reduced
cASCs proliferation in concentrations of 10–200ng/mL culture medium. A combination of HMGA1 and HMGA2 protein (100
and200ng/mLeach)causedthesameeﬀects,whereasnosigniﬁcanteﬀectoncASCsproliferationwasshownafterHMGA2protein
application alone. RT-qPCR results showed that expression levels of marker genes including KLF4, SOX2, OCT4, HMGA2, and
cMYCmRNAswereonthesamelevelinbothHMGA2-protein-stimulatedand-unstimulatedcASCs.ExtracellularHMGAprotein
application might be valuable to control proliferation of cASCs in context with their employment in regenerative approaches
without aﬀecting their self-renewal and multipotency abilities.
1.Introduction
Mesenchymalstemcells(MSCs)areconsideredasonesource
of progenitor cells for therapeutic approaches in regen-
erative medicine. Although MSCs are commonly derived
from bone marrow (BMSCs) [1], adipose-tissue-derived
MSCs (ASCs) might be used as an alternative multipotent
cell source [2–4]. Similar to BMSCs, ASCs have been also
evaluated for multilineage diﬀerentiation capacities includ-
ing diﬀerentiation into a chondrogenic [5, 6], osteogenic
[5–7], adipogenic [5–7], neurogenic [8, 9], myogenic [6,
8, 10], angiogenic [11], and cardiomyogenic [10] lineage.
In contrast to bone marrow, a large amount of adipose
tissue can easily be obtained via less invasive and harmful
methods making the use of ASCs as a source of stem
cells very attractive [12]. Furthermore, it has recently been
reported that ASCs have stronger capabilities than BMSCs
to maintain their phenotype and multipotency potential
even after 25 passages of in vitro cultivation [10]. The self-
renewal and multipotency characteristics through regular
andorganizedcelldivisionarethemostimportantfeaturesof
stem cells to persist throughout life in tissues. These features
are regulated by stem-cell-speciﬁc transcription factors, so-
called multipotency genes, including SOX2 [13], cMYC [14],
KLF4 [15], OCT4 [13, 16], NANOG [16], UTF1 [17], and
LIN28 [18]. For maintaining the self-renewal ability of
MSCs, the balance of growth factors and signaling molecules
is strongly required. Therefore, the recognition of the key
environmental cues that regulate the phenomena of steady
proliferation and self-renewal of adult stem cells is crucial
for both in vitro and in vivo applications. On this occasion,
recent studies have shown that HMGA proteins have the
potential to maintain and inﬂuence eﬃciently these features
[19–21]. The high-mobility group A (HMGA) proteins2 Veterinary Medicine International
(formerly known as HMGI/Y) are a class of large and
specialized nuclear nonhistone chromosomal architectural
proteins [22, 23]. The common functional and structural
motifsinthisuniquegrouparethreeDNA-bindingdomains,
so-called AT hooks, which bind preferentially to short AT-
rich DNA sequences and an acidic C-terminus [24]. HMGA
proteins are encoded by two distinct genes, HMGA1 and
HMGA2 [25]. High expression of both HMGA proteins in
undiﬀerentiated and proliferating mesenchymal cells of early
embryos indicate an important role of HMGA proteins in
the regulation of stem cell proliferation and diﬀerentiation
[26]. HMGA1 is mainly expressed during cell diﬀerentiation,
whereas HMGA2 expression is mainly present during cell
growth and proliferation [27].
HMGA2 expression is present in human and mouse
ES cells in the inner cell mass of blastocysts indicating
a key role of these proteins during prenatal development
and growth [26, 28]. Furthermore, it has been found that
HMGA2 expression in pluripotent human ES is closely
correlated to the expression of pluripotency speciﬁc genes
UTF1, SOX2, and OCT4 [29]. Additionally, Eda et al. [30]
have investigated that HMGA2 and LIN28 were down-
regulated upon upregulation of let-7, miR-9, and miR-
125b microRNAs after neuronal induction of mouse P19
embryonic carcinoma cells. In contrast Nishino et al. [19]
have found that self-renewal of mouse neural stem cells was
maintained by downregulation of P16 (INK4a), P19 (Arf),
and let-7b microRNA upon HMGA2-mediated expression.
With regard to the eﬀects of HMGA1 expression on cell
proliferation, one previous in vitro study has demonstrated
that downregulation of cMYC transcripts in gastric cancer
celllines led to aninhibition of HMGA1 expression upon the
wnt3a/beta-catenin pathway ﬁnally resulting in reduced cell
growthandproliferation[31].TheroleoftruncatedHMGA1
protein has been evaluated for an increased adipocytic cell
growth as well as development of human lipomas through
its rearrangements [32]. Only few in vitro studies have
been carried out to evaluate the role of HMGA proteins
on proliferation of both undiﬀerentiated embryonic stem
c e l l sa sw e l la sa l r e a d yd i ﬀerentiated cells. Caron et al.
[33] have suggested that the HMGA2 transcription factor
has a function in skeletal myogenesis of mouse embryonic
cells. Li et al. [29] have demonstrated regulatory inﬂuences
of HMGA2 protein expression on genes linked to human
ES cell growth, mesenchymal stem cell diﬀerentiation, and
adipogenic diﬀerentiation. Richter et al. [34]h a v ef o u n d
that HMGA1a, HMGA1b, and HMGA2 protein application
in vitro results in a strong positive eﬀect on proliferation
of chondrocytes derived from porcine hyalin cartilage. In
conclusion HMGA proteins are considered to play a crucial
role in regulating the expression of many diﬀerent genes
important for cell growth and proliferation, especially of
stem cells. On the basis of the introduced literature, one
hypothesis of this study is that the proliferation rate of
cultivated stem cells, for example, ASCs, can be enhanced or
decreased by either HMGA2 or HMGA1 protein application
without having an eﬀect on the multipotent status of the
cells. For a possible future in vivo usage of stem cells in
context with regenerative or tumour therapies in dogs as
well as in humans it is highly desirable to control their
proliferation, for example, by local application of proteins
at the target site. The dog represents a valuable biomedical
model for evaluation of novel therapeutic approaches in
human medicine and for the dog itself. Additionally, the
dog genome is highly similar to the human genome, making
it an ideal model organism for the development of human
cell and gene therapeutic approaches [35]. Therefore, our
studywasconductedtoevaluatetheeﬀectofHMGAProteins
on canine ASCs. However, the inﬂuence of ectopic HMGA1
and HMGA2 protein application on cultivated ASCS is so
far unknown. Thus, the aim of the present study was to
evaluate the in vitro inﬂuence of HMGA proteins on canine
ASCsproliferationandself-renewal.Moreover,itintendedto
investigate expression levels of multipotency speciﬁc marker
genes in HMGA2 stimulated and unstimulated cASCs.
2.MaterialsandMethods
2.1. Isolation and Cultivation of cASCs. All experiments were
carriedoutinaccordancewiththeGermanlawguidelinesfor
governing the care and use of animals [TSchG, §4(3)]. The
methods used for isolation of canine adipose-derived mes-
enchymal stem cells (cASCs) were adapted from previously
published protocols as described by Zuk et al. [6]. Brieﬂy,
adipose tissue samples were obtained from subcutaneous
fat depots of healthy dogs, weighed and then minced into
small pieces. In total 20 subcutaneous fat samples of 20 dogs
of diﬀerent breeds were harvested. These dogs underwent
orthopaedic surgeries or ovariohysterectomies and had no
any other evident disease. The tissue pieces were enzymati-
cally dissociated at 37◦C for 30min with 0.026% collagenase
I( S i g m a ,S t .L o u i s ,M O . ,U S A ) .E n z y m ea c t i v i t yw a sn e u -
tralized with Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Biochrom AG, Berlin) containing 10% fetal calf serum
(FCS, PAA Laboratories GmbH, Austria). Afterwards, the
digested fat samples were ﬁltered using a 100μm cell strainer
(BD Bioscience, Bedford, USA) to remove debris. The cell
pellets obtained after centrifugation were resuspended in
DMEM with 10% FCS and plated in 25cm2 ﬂasks (TPP
AG, Switzerland). The cultured cells were then maintained
in an incubator supplied with humidiﬁed atmosphere of
5% CO2 and 95% air at 37◦C. Next day, the medium was
exchanged in order to remove cell debris and red blood cells.
Medium change was performed every second day. When the
monolayer of adherent cells reached approximately 70–80%
conﬂuence; trypsinization for cell splitting was performed
using trypsin-EDTA solution (0.05%/0.02%, Biochrom AG,
Berlin, Germany). After centrifugation, the cell pellets were
subcultured at a concentration of 3 × 105 cells/mL medium
on 25cm2 tissue culture ﬂasks containing DMEM/10% FCS.
Cell counting was carried out by an automatic cell counter
(Cellometer Nexcelom Bioscience, Lawrence, USA).
2.2. Multilineage Diﬀerentiation Capacity of cASCs. cASCs
at passage 3 were veriﬁed for their developmental capacity
to diﬀerentiate into cells of the osteogenic, adipogenic, and
chondrogenic lineage. For each diﬀerentiation experiment
three 25cm2 tissue culture ﬂasks were used. In addition,Veterinary Medicine International 3
each diﬀerentiation experiment was repeated more than one
time.
2.3. Osteogenic Diﬀerentiation of cASCs. For osteogenic dif-
ferentiation, cASCs at passage 3 were cultured in 25cm2
ﬂasks at a concentration of 6×105 in presence of osteogenic
induction medium for 5 weeks. Osteogenic induction
medium was prepared as previously described by Pittenger
et al. [36]. DMEM containing 10% FCS was supplemented
withdexamethasone(Dexa,#D8893,Sigma-AldrichChemie
GmbH, Steinheim, Germany) at a concentration of 0.1μM,
2-phospho-L-ascorbic acid trisodium salts (Asc 2P; # 49752,
Sigma-Aldrich Chemie) at a concentration of 50μM, and
β-glycerophosphate disodium at a concentration of 10mM
(# 50020, Sigma-Aldrich Chemie). Osteogenic induction
medium was changed every third day. Negative controls
consisted of cASCs cells maintained in DMEM with 10%
FCS. Before staining, the cells were washed with PBS (2
times) and ﬁxed in 4% paraformaldehyde solution (PFA)
for 10min at room temperature, followed again by rinsing
3 times with PBS. To verify osteogenic diﬀerentiation, von
Kossastainingwascarriedouttodetectcalciﬁedextracellular
matrix deposits (ECM).
2.4. Chondrogenic Diﬀerentiation of cASCs. For chondro-
genic induction, the micromass culture technique was used
[37] .c A S C sa tp a s s a g e2w e r es e e d e do u ti n2 5 c m 2 ﬂasks
(with ﬂat cultivation surface) using chondrogenic induction
medium at a concentration of 2×106/ﬂask. Chondro-
genic induction medium consisted of DMEM, 10% FCS,
0.1μMD e x a ,5 0 μM Asc-2p, 0.35g/100mL D(+)-glucose
(# G-7021, Sigma-Aldrich Chemie), 50mg/mL (1x) ITS +
1 liquid media supplement (10μg/mL insulin, 5.5μg/mL
transferrin, 5ng/mL selenium, 0.5mg/mL bovine albumin,
4.7μg/mL linoleic acid) (# I-2521, Sigma-Aldrich Chemie),
and 10ng/mL transforming growth factor (rhTGF-β1; #100-
21, PeproTech GmbH, Hamburg, Germany). After seeding,
cells were allowed to adhere for 4 hours (37◦C, humidiﬁed
atmosphere, 5% CO2). Afterwards, the cells were maintained
in induction medium for 21 days. The culture medium
was changed every third day. Negative controls consisted of
cASCs maintained in noninductive basal medium. Fixation
of the cells was carried out as described above. Chondro-
genic induction was conﬁrmed by Alcian blue staining for
chondrocyte-speciﬁc proteoglycans.
2.5. Adipogenic Diﬀerentiation of cASCs. For adipogenic
induction, cASCs were seeded in 25cm2 ﬂ a s k sa tac o n -
centration of 2×106 cells/ﬂask using DMEM medium
containing 10% FCS. After a cultivation period of 3h the
medium was discarded, followed by a cultivation period
of 72h in adipogenic induction medium. Adipogenic
induction medium consisted of DMEM supplemented with
10% FCS, 1μMd e x a ,1 0 μg/mL insulin (# I-6634, Sigma-
Aldrich Chemie), 100μM indomethacin (#I-7378, Sigma-
Aldrich Chemie), and 500μM isobutylmethylxanthine (#I-
5879, Sigma-Aldrich Chemie GmbH, Steinheim, Germany).
After removal of adipogenic induction medium the cells
were cultivated for 24h in adipogenic maintenance medium
consisting of DMEM basalmedium, 10% FCS, and 10μg/mL
insulin.Cellswerethencultivatedagaininadipogenicinduc-
tionmediumfor72h,followedbyanother24hinadipogenic
maintenance medium. This cycle was repeated four times
in total (16d), followed by one week of cultivation in adi-
pogenic maintenance medium. Negative controls consisted
of cASCs maintained in noninductive basal medium for 23
days. Fixation of the cells was carried out as described above.
Adipogenic diﬀerentiation was conﬁrmed by intracellular
lipid droplets accumulation after Oil Red O staining.
2.6. In Vitro cASCs Proliferation Assay. cASCs were harvested
by trypsinization and resuspended in fresh tissue culture
medium as described above. The viable cell percentage
from the harvested cells was calculated after trypan blue
staining by an automatic cell counter (Cellometer Nex-
celom Bioscience, Lawrence, USA). The cell concentration
used for the proliferation assay was adjusted to 7×103
cells/100μL medium. Liquid HMGA protein solution of
HMGA1 (#:TP301458, AMS Biotechnology, Ltd, Germany)
and HMGA2 (#H00008091-Q01, Abnova, Germany) were
added to the DMEM culture medium with 10% FCS at
concentrations of 10, 50, 100, and 200ng/mL. Furthermore
a combination of HMGA1 and HMGA2 (100 and 200ng/mL
each) was used for cASC stimulation. The negative control
condition consisted of unstimulated cASCs. To achieve
the correct protein concentrations in the culture medium,
directly before usage, stock solutions with protein concen-
trations of 1μg/mL DMEM culture medium (with 10%
FCS) were prepared. The desired concentration of HMGA
proteins was achieved by further dilution of the stock
solution with DMEM (with 10% FCS). Proliferation of
stimulated and unstimulated cASCs was evaluated using a
bromodeoxyuridine (BrdU) cell proliferation enzyme-linked
immunosorbent assay (ELISA kit; #11647229001, Roche
Diagnostics GmbH, Mannheim, Germany) according to the
manufacturer’sinstructions.Foreachoftheanalyzedprotein
concentrations cASCs were seeded out in eight separate wells
of a 96-well cell culture microtiter plate (#353075, Microtest-
Falcon, Becton Dickinson Biosciences, USA) at a concen-
tration of 7×103 cells per well (100μL of cell suspension).
Cells were incubated for 3 hours (95% humidiﬁed air, 37◦C,
5% CO2) for cell adhesion, followed by the addition of the
corresponding amounts of each protein. After a coculturing
period of 24 hours (95% humidiﬁed air, 37◦C, 5% CO2),
10μL/well of BrdU labeling solution (ﬁnal concentration;
10μm/well BrdU) was added, followed by reincubation at
37◦C and 5% CO2 for another 24h. During this labeling
period,thepyrimidineanalogueBrdUwasincorporatedinto
the DNA of the proliferating cASCs. After 48 hours as a total
treatmentperiodofHMGAprotein,theculturemediumwas
carefully removed. Afterwards, the cells were ﬁxed and the
DNA was denatured in one step by adding FixDenat solution
(200μL/well). The cells were then incubated for half an hour
at room temperature. The denaturation of the DNA was
necessary to improve the accessibility of the incorporated
BrdU for detection by the antibody. FixDenat solution
was removed thoroughly via careful pipetting. Anti-BrdU-
conjugate-peroxidase (Anti-BrdU-POD) working solution4 Veterinary Medicine International
wasthenaddedinanamountof100μL/well.Theanti-BrdU-
POD binds to the BrdU incorporated in newly synthesized,
cellular DNA. After 90 minutes incubation at RT, the
antibody conjugate was removed. Afterwards, the cells were
rinsed three times with washing solution (PBS; 300μL/well).
The immune complexes were detected by the subsequent
substrate reaction. Finally the substrate solution (TMB;
tetramethyl-benzidine) was added to the cells (100μL/well),
and the cells were incubated at RT for another 25 minutes.
The photometric absorbance values of the reaction products
were measured using a scanning multiwell spectropho-
tometer (Synergy 2 Multi-Mode Microplate Reader, Biotek
Instruments GmbH. Germany) at 370nm and a reference
wavelength of 492nm at 10 time points between 0 and
30 minutes. The blanked 370nm data minor 497nm were
plotted against the timescale. The maximal slope of the
absorbance curve was calculated and used for statistical
comparisons. The absorbance values directly correlate to
the amount of synthesized DNA and the corresponding
number of proliferating cells in the respective microcultures.
Absorbance values for the negative control condition were
normalized to 100%. Values of all other conditions were
converted, respectively.
2.7. Stimulation of cASCs with HMGA2 Protein for Subse-
quent RT-qPCR. According to the above-mentioned pro-
tocols cASCs were seeded in six-well tissue culture plates
at a concentration of 2×104 cells/well in DMEM (vol-
ume/well:1000μL) supplemented with 10% FCS. Cells were
allowed to adhere for 4 hours. Afterwards cASCs were stim-
ulated in triplicates with HMGA2 supplemented medium
at a concentration of 50 and 100ng HMGA2/mL culture
medium (volume/well:1000μL). Unstimulated cASCs served
as control. After incubation for 48 hours (humidiﬁed
atmosphere, 5% CO2,3 7 ◦C) the cells were harvested by
trypsinization, followed by centrifugation at 800×gf o r1 0
minutes. The cell pellet was used for subsequent RT-qPCR.
2.8. Relative Quantitative Real-Time Polymerase Chain
Reaction (RT-qPCR)
2.8.1. RNA Isolation and cDNA Synthesis for Transcript Char-
acterization. Total RNA was isolated from unstimulated as
wellasHMGA2stimulatedcASCs(100,200ng)usingNucle-
oSpin miRNA (#740971.250; Macherey & Nagel GmbH,
D¨ uren. Germany) isolation kit according to the manufac-
turer’s instructions. The concentration and purity of the
isolated RNA was veriﬁed by the OD260/280nm absorption
ratio using the Multi-Mode Microplate Reader SynergyTM2
and Gene5TM microplate software (Biotek Instruments, inc,
USA). cDNA was synthesised using Quantitect Reverse Tran-
scription Kit (#205313; Qiagen, Hilden, Germany) following
the manufacturer’s protocol. For the reverse transcription,
250ng of total RNA were used for the relative characteri-
zation of mRNA transcript levels of Klf4, HMGA2, SOX2,
cMYC, NANOG, and Pou5F/OCT4.
2.8.2. RT-qPCR. RT-qPCR was carried out using the Master
Cycler Gradient Cycler (Eppendorf, Germany). The canine
Hypoxanthine Phosphoribosyl Transferase-1 (HPRT1) [38]
and Glucuronidase Beta transcript (GUSB) [39] were used as
endogenous reference genes. The ampliﬁcation was carried
out in a total reaction volume of 20μL using the TaqMan
Universal PCR Master Mix (# 4304437; Applied Biosystems,
Darmstadt, Germany). For establishing the canine HMGA2-
and Klf4-Assays, the primers and probes were designed
by the software SeqMan Pro and Editseq 7.1.0 DNAS-
TAR, Inc. (Lasergene MADISON, USA) using the murine
KLF4 mRNA NM 010637, human KLF4 mRNA NM 004235
(http://www.ncbi.nlm.nih.gov/), and canine KLF4 cDNA
ENSCAFT00000004467 (http://www.ensembl.org/). The de-
signed primers and probes related to KLF4 and HMGA2
mRNA were supplied by Biomers (Ulm, Germany). The
Primerandprobesequencesofallotherexaminedtranscripts
were synthesized by Applied Biosystems (Darmstadt, Ger-
many). For ampliﬁcation of gene transcripts, 500nM of
each primer and 200nM of the corresponding ﬂuorogenic
probe were used. Form each sample 2μL cDNA were used
as template. All reactions were carried out on the same
RT-qPCR plate. PCR cycles were carried out starting with
2min for activation at 50◦Ca n d1 0m i na t9 5 ◦C for template
denaturation, followed by 40 cycles with 15s at 95◦Ca n d
1min at 60 ◦C. All samples were measured in triplicate
and for each run nontemplate controls and nonreverse
transcriptase control reactions were included. The quotient
of the threshold cycles for the analysed multipotency marker
genes was set in relation to the expression level of the
housekeeping genes HPRT1 and GUSB using the ΔΔ cycle
threshold (ΔΔCT) method. Gene expression levels of the
marker genes in HMGA2 stimulated cASCs were normalised
to the expression level in unstimulated cASCs.
2.8.3. Statistics. The statistical analyses were performed us-
ingGraphPadPrism4software(GraphPadSoftware,LaJolla,
CA). The obtained data were expressed as means ± SD.
Diﬀerences between groups were analyzed using a one-way
ANOVA and a Tukey test for post hoc comparisons. The
s i g n i ﬁ c a n c el e v e l sw e r es e ta tP<0.05, P<0.01 and P<
0.001.
3. Results
3.1. Morphology of Canine ASCs. After 24 hours of cultiva-
tion, most of the seeded cells were remaining nonadherent
in suspension. After washing to remove these cells, few
adhered single cells or cell aggregates were observed. Initially
adherent cells grew into spindle or ﬁbroblast-like cells,
which then developed into visible colonies after 3–5 days
in culture. Furthermore, formation of cell-cell contacts and
proliferation could be observed. After a cultivation period of
two weeks adherent cells had proliferated to near conﬂuence
in 25cm2 ﬂasks. After the ﬁrst passage, the ﬁbroblast-
like shape became more regular and could be maintained
throughout further subcultivation (Figure 1(a)).
3.2. Demonstration of Multilineage Potential of cASCs. cASCs
isolated from subcutaneous fat were evaluated for their abil-
ity to diﬀerentiate into cells with an osteogenic (Figure 1(b)),Veterinary Medicine International 5
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Figure 1: Example of Diﬀ-Quik stained undiﬀerentiated cASCs with ﬂattened ﬁbroblast-like morphology (a). After 5 weeks of osteogenic
induction, von Kossa staining was positive, showing large black calcifying nodules (b). Chondrogenic diﬀerentiated cASCs show polygonal
morphology after 21 days of induction in addition to positive Alcian blue staining of the chondrocyte-speciﬁc glycosaminoglycans (c). In (c)
an adherent double cell layer is to be seen. Adipogenic induction could be shown 23 days after induction by positive red lipid droplets after
Oil Red O staining (d). Scale bar: 200μm (a–c) and 100μm (d).
chondrogenic (Figure 1(c)), and adipogenic (Figure 1(d))
phenotype after cultivation in a respectively supplemented
medium (see below).
3.3.OsteogenicDiﬀerentiation. Aftertwoweeksofcultivation
in presence of osteogenic induction medium, cells changed
from a ﬁbroblastic phenotype to a more polygonal appear-
ance. Furthermore, a small amount of the calcium deposi-
tion, normally indicative for osteogenesis, could be detected.
Additionally, osteogenic diﬀerentiation was conﬁrmed by
positive von Kossa staining. Within a cultivation period of
5 weeks after induction of the cells continued to proliferate
activelyandformedcellaggregateswithanincreasedamount
of calciﬁed extracellular matrix and mineralized nodules
(Figure 1(b)). These ﬁndings were absent in cultures of
unstimulated cASCs which maintained their ﬁbroblast-like
appearance and did not form cell aggregates (Figure 1(a)).
Furthermore,nocalciﬁedECMdepositioncouldbeobserved
in undiﬀerentiated cells.
3.4. Chondrogenic Diﬀerentiation. Chondrogenic diﬀerenti-
ation of cASCs was achieved after 3 weeks of micromass
culture in chondrogenic induction medium. At this time-
point chondrocyte-diﬀerentiated cASCs showed a polygonal
morphology. Furthermore, chondrogenic induction was
conﬁrmed by positive Alcian blue staining which is indica-
tive for the presence of chondrocyte-speciﬁc proteoglycans
(Figure 1(c)). Positive Alcian blue staining was absent in
unstimulated cASCs (Figure 1(a)).
3.5. Adipogenic Diﬀerentiation. Adipogenic induction of
cASCs was completed after 23 days of cultivation in adi-
pogenicinductionmedium.Adipogeniccellsshowedalarger
cell morphology with an accumulation of red intracellular6 Veterinary Medicine International
cADMSC proliferation assay
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Figure 2: Proliferation test of cASCs stimulated with HMGA pro-
teins. Absorbance values were normalized to 100% in the negative
control condition, signiﬁcance levels are given for comparisons
versus negative control condition. HMGA1 at all used levels has
signiﬁcant suppressive eﬀects on cell proliferation (P<0.001). In
contrast, cell proliferation in the HMGA2-treated groups resulted
in no signiﬁcant diﬀerences in comparison to the control group
at all chosen concentrations. The combined protein application
of 100ng and 200ng/mL shows a signiﬁcant suppressive eﬀect on
cASCs proliferation (P<0.001). For statistical comparisons a
one-way analysis of variance and a Tukey posttest was carried out
(signiﬁcance levels: ∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001).
lipid droplets after Oil Red O staining (Figure 1(d)). Positive
OilRedOstainingandchangedcellmorphologywereabsent
in unstimulated cASCs (Figure 1(a)).
3.6. Eﬀect of HMGA Proteins on Proliferation Rate of cASCs.
To evaluate whether HMGA proteins have an eﬀect on
proliferation of cASCs, cells were cocultured for 48 hours
in presence of HMGA1 and HMGA2 proteins at diﬀer-
ent concentrations and in combination with each other.
HMGA1 and HMGA2 related eﬀects on cASC proliferation
were compared with proliferation rates of non-HMGA-
treated cASCs (Figure 2). No signiﬁcant enhancement of
cASC proliferation after HMGA2 protein application at
concentrations of 10 (94.99 ± 12.44% (mean ± standard
deviation)), 50 (99.46 ± 13.07%), 100 (95.79 ± 9.95%),
and 200 (92.55 ± 6.95%)ng/mL could be detected in
comparison to the proliferation rate of unstimulated cASCs
(100 ± 18.04%). In contrast, HMGA1 protein application at
concentrations of 10 (44.73 ± 12.37%), 50 (42.5 ± 9.05%),
100 (55.49 ± 16.83%), and 200 (48.7 ± 4.81%)ng/mL had
a signiﬁcant inhibitory eﬀect on cASC proliferation (P<
0.001). Moreover, the combined application of HMGA1 and
HMGA2 protein at respective concentrations of 100 (60.82
± 32.04%) and 200 (55.62 ±10.93%)ng/mL also resulted
in a signiﬁcant decrease of the cell proliferation rate (P<
0.001), when compared with untreated cells. Furthermore
the proliferation rate of combined HMGA1- and HMGA2-
treated cASCs was found to be on the same level as in
HMGA1 stimulated cells in all used concentrations.
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Figure 3: Marker gene expression in HMGA2 protein-stimulated
(50, 100ng/mL) and -unstimulated cASCs (relative expression = 1)
afterRT-qPCR.HPRTwasusedasendogenouscontrol.Allanalysed
genes (cMYC, SOX2, KLF4, HMGA2, and OCT4) are expressed in
cASCs. No signiﬁcant marker gene regulation could be detected
after HMGA2 application in both concentrations.
3.7. Expression Analyzes of Multipotency Marker Genes in
HMGA2-Stimulated cASCs. Relative expression of all ana-
lyzed marker genes in unstimulated cASCs was normalized
t o1( F i g u r e s3 and 4) and gene expression in the 50
and 100ng/mL stimulated cASC condition was normalized
accordingly. In case of the experiments in which HPRT1
(Figure 3) was used as endogenous control, KLF4 expression
higher in 50 (1.55 ± 0.09) and 100ng/mL (1.46 ± 0.04;
P<0.05) HMGA2-treated cASCS than in ustimulated
cASCs. However, these diﬀerences were not signiﬁcant.
OCT4 expression in relation to HPRT1 in stimulated cASCs
was measured on the same level as in unstimulated cASCs
after 50 (0.99 ± 0.53; P>0.05) and 100ng/mL (1.26 ± 0.09;
P>0.05)HMGA2treatment.Nosigniﬁcantdiﬀerenceswere
found for SOX2, cMYC, and HMGA2 expression in relation
to HPRT1 in cASCs after 50 (SOX2: 0.94 ± 0.04, P>0.05;
cMYC:1.00 ±0.07,P>0.05;HMGA2:0.83 ±0.13,P>0.05)
and 100ng/mL (SOX2: 1.05 ± 0.09, P>0.05; cMYC: 0.81 ±
0.07, P>0.05; HMGA2: 1.05 ± 0.11, P>0.05) HMGA2
stimulation in comparison to unstimulated cASCs.
In case of GUSB (Figure 4) as endogenous control no
signiﬁcant diﬀerences with regard to KLF4 expression could
be detected in cASCs after 50 (1.06 ± 0.09; P>0.05) and
100ng/mL (1.22 ± 0.04; P>0.05) HMGA2 stimulation
in comparison to unstimulated cells. OCT4 expression in
relation to GUSB was slightly but not signiﬁcantly lower in
50 (0.61 ± 0.07; P>0.05) and 100ng/mL (0.78 ± 0.56; P>
0.05)HMGA2-treatedcASCsincomparisontounstimulated
cells. No signiﬁcant diﬀerences were found for SOX2, cMYCVeterinary Medicine International 7
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Figure 4: Marker gene expression in HMGA2 protein-stimulated
(50, 100 ng/mL) and -unstimulated cASCs (1) after RT-qPCR.
GUSB was used as endogenous control. All analysed genes (cMYC,
SOX2, KLF4, HMGA2, and OCT4) are expressed in cASCs. No
signiﬁcant marker gene regulation could be detected after HMGA2
application in both concentrations.
and HMGA2 expression in relation to HPRT1 in cASCs after
50 (SOX2: 0.64 ± 0.01, P>0.05; cMYC: 0.73 ± 0.01, P>
0.05; HMGA2: 0.86 ± 0.02, P>0.05) and 100ng/mL (SOX2:
0.79 ± 0.09, P>0.05; cMYC:0.90 ± 0.05, P>0.05; HMGA2:
1.33 ±0.18,P>0.05)HMGA2stimulationincomparisonto
unstimulated cASCs.
4. Discussion
In the ﬁeld of tissue engineering, a setup of well-deﬁned and
reproduciblecultureconditions thatwillallowforlarge-scale
expansion of stem cells while providing eﬃcient self-renewal
and maintenance of multipotency is critical. The key factor
in terms of multipotency and self-renewal characteristics of
stem cells is the control by the expression of several unique
multipotency-associated marker genes as for example, KLF4,
cMYC, SOX2, HMGA2, and OCT4 [13–16, 40].
The present study was focused on the characterization of
multipotent eﬀects of HMGA protein application on culti-
vated cASCs. These adipose-tissue-derived cells have several
beneﬁts for clinical applications, providing an autologous
source of adult stem cells for therapeutic approaches [41]. In
general the isolation of these cells from mammalian tissues
is well established as well as the possibility to expand the
cells in vitro. Thereby, the potential of cASCs to diﬀerentiate
into osteogenic, adipogenic, and chondrogenic lineages is
preserved conﬁrming the stem-cell-like character of the cells
kept in vitro. Multilineage diﬀerentiation capacity could also
bedemonstratedbyhistologicanalysesforcASCsusedinthis
study. As the diﬀerentiation procedure is a well-established
technique [36, 37] further negative controls using, for
example, Alcian blue stained undiﬀerentiated cASCs are not
presented, which is, however a shortcoming of the here pre-
sentedstudy.Recentlyitcouldbeshown,thatadultcASCsdo
not lose their stem cell features after cryopreservation [42].
B e s i d e sA S C s[ 5, 6], these facts are also valid for mammalian
BMSCs [43]. Previous studies demonstrated that the HMGA
proteins HMGA1 and HMGA2 are involved in various
c e l l u l a rp r o c e s s e ss u c ha sp r o l i f e r a t i o n[ 24] and senescence
[44]. In addition, they are highly expressed in undiﬀer-
entiated cells during embryogenesis and downregulated in
diﬀerentiatedcells[28].Consequently,inthepresentedstudy
proliferative eﬀects as well as eﬀects on regulation on stem
cell marker genes of cASCs were characterized in vitro.O u r
data indicated that HMGA1 protein at concentrations of
10ng to 200ng/mL culture medium as well as a combined
protein application of HMGA1 and HMGA2 (100 and
200ng/mL) resulted in signiﬁcant suppressive eﬀects on
cASCs proliferation after 48 hours of cocultivation. These
ﬁndings are contrary to an earlier study which reported a
reduced cell growth and proliferation due to a decreased
HMGA1 expression in gastric cancer cell lines [31]. An
explanation for the diﬀerent response of cASCs to ectopic
HMGA1 application might be that functional pathways in
cancer cell lines are often not comparable to the pathways of
physiological somatic cells or stem cells. In the present study
nosigniﬁcantdiﬀerenceofcASCproliferationincomparison
to untreated cASCs could be found after HMGA2 protein
application at all used concentrations. In contrast, Richter et
al. [34] were able to demonstrate that HMGA1a, HMGA1b,
and HMGA2 proteins have a signiﬁcant positive eﬀect on
the proliferation rate of chondrocyte monolayers in vitro
after 24 hours of incubation. In another recently published
study, Richter et al. found positive proliferative eﬀects of
HMGA2-derived fragments on proliferation of cultured
porcine chondrocytes and canine ASCs [34, 45]. However,
higher doses of HMG proteins ranging from 1μgt oo v e r
100μg/mL were used in the studies of Richter et al. [34, 45].
In the here presented study lower doses of HMG protein
were used according to the studies performed with the
HMGAsisterproteinHMGB1demonstratingbiologiceﬀects
at concentrations of 10–200ng/mL protein application [46,
47]. However, in this context it has to be kept in mind
that HMGB1 extracellular signaling is well characterised
being mediated by TLR and RAGE receptors. In contrast
to this, a detailed characterisation of extracellular HMGA
receptors is still missing. To our knowledge, only few
studies have been carried out to verify how HMGA proteins
aﬀect multipotency maintenance and proliferation in adult
stem cells. Recently, Nishino et al. [19] have reported that
HMGA2 protein knockdown led to inhibition of neural
stem cell proliferation and self-renewal of fetal and young-
adult mice but not old-adult mice. These ﬁndings indicate
that HMGA2 might have a proliferative eﬀect only on stem
cells at early stages. This hypothesis is supported by the
results of our in vitro study in which also no proliferative
eﬀects of HMGA2 could be found. Nevertheless it has to be
stated that in our study an extracellular protein application8 Veterinary Medicine International
was used, whereas in the study of Nishino et al., HMGA2
expression was knocked out [19]. In addition, microRNA
let-7b has been reported to regulate self-renewal of neural
stem cells through targeting on HMGA2 protein and TLX
receptor [19, 48]. Our results reported here using real-
time qPCR revealed that HMGA2 protein can contribute
to maintain self-renewal and multipotency of cASCs as
no signiﬁcant eﬀects on gene regulation of multipotency
marker genes could be found. HMGA2 protein-stimulated
and -unstimulated cASCs showed no signiﬁcant diﬀerences
in relative expression levels of the marker genes KLF4, SOX2,
OCT4, cMYC, and HMGA2 in cASCs. In this context it
has to be stated that the OCT4 signal was detectable only
at late PCR cycles. Thus, results for this gene have to be
looked at critically. However, for reasons of a complete
description of the gene panel the OCT4 data is presented.
A major limitation of the study is the missing data of marker
geneexpressionsincASCsafterHMGA1proteinapplication.
Therefore, future studies will have to investigate whether the
inhibitory eﬀect on cASC proliferation is accompanied by
a changed or unaltered expression of multipotency marker
genes. As another result, it could be demonstrated that
the suppressive eﬀects of HMGA1 protein application on
cASC proliferation cannot be blocked by additional HMGA2
application. In case of the combined HMGA1 and HMGA2
application in a concentration of 100ng/mL each, a high-
standard deviation of the measurement values is evident.
However, it would be interesting to investigate the eﬀects
of HMGA1 protein application on gene expression of the
mentioned marker genes and to check for HMGA1 spe-
ciﬁc receptors on cASCs. Also, multilineage diﬀerentiation
capacity of HMGA protein-stimulated ASCs remains to be
investigated in further studies.
5. Conclusions
In conclusion, HMGA proteins remain interesting candidate
proteins for inﬂuencing ASC proliferation without altering
multipotency gene expression. Further studies focussing on
higher concentrations of HMGA protein application on
cultured ASCs are needed to fully study the eﬀects on
proliferationandmarkergeneexpression. Characterizingthe
role of HMGA protein on self-renewal and multipotency of
ASCs might be providing novel insights for a controlled and
eﬃcient application of these cells in regenerative approaches.
Especially the possibility to control proliferation of tumour
stem cells would be of great advantage in this context.
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